Beginnings, endings and transitions: Janus and the business of pharmaceuticals
Dr Kevin Robinson recently caught up with pharmaceutical industry experts to review what they considered to be the sector’s key challenges and achievements in 2024 and what trends, technologies or regulatory shifts they anticipate will shape the industry in 2025